Introduction
============

Epigenetics can induce changes in gene expression without altering the DNA sequence, thus affecting cellular ohenotype [@B1]. Living cells have tightly controlled and pre-programmed mechanisms to regulate epigenetic events. These events can also be altered by various factors, including environmental conditions, such as exposure to toxins, as well as by age, behavior, a specific disease, etc. Typically, these changes are not inherited, but they can be passed on to the next generation if the changes occur in a sperm or egg cell. Epigenetic regulation is thought to be primarily controlled through DNA methylation and histone modification and in part by non-coding RNAs (ncRNAs) [@B2]-[@B4]. In eukaryotic organisms, DNA winds around histone proteins, forming a complex called chromatin. The structural units of chromatin are nucleosomes, which consist of 147 base pairs of DNA wrapped around a octamer core of histone proteins [@B5]. The octamer core contains two of each of the histone proteins (H2A, H2B, H3, and H4). Two nucleosomes are in turn connected by a linker histone (H1), which contributes to the stability of the structure. Post-translational modifications at the N-terminus of the histone proteins are reffered to as histone modifications. These modifications include acetylation, methylation, phosphorylation, ubiquitinylation, ADP-ribosylation, and sumoylation of histone proteins [@B6]-[@B9]. Histone modifications can influence chromatin structure and the subsequent regulation of gene expression. Based on current knowledge, it is understood that histone acetylation is associated with active gene transcription, whereas histone methylation is associated with the suppression of transcription [@B10].

The exposure of cells to any toxin can result in harmful effects. The cells that are most vulnerable are those that are in the process of development and differentiation. Thus, the developing fetus is highly affected by alcohol exposure because the whole body is under development during the embryonic stage. It was well established that alcohol intake during pregnancy can result in abnormalities in infants. The types of abnormalities that result from ethanol exposure vary depending on the dose, duration, and frequency of consumption during the gestational period. Maternal genetics and metabolism are also important factors that can influence the developmental process [@B11]. Fetal alcohol spectrum disorder (FASD) is a term that is commonly used to refer to alcohol-related abnormalities *in utero* [@B12], [@B13]. Fetal alcohol syndrome (FAS) is the most severe form of FASD and includes growth retardation, craniofacial defects, and central nervous system (CNS) deficits [@B14], [@B15]. The developing fetus that is in the embryonic stage is known to be more severely affected by alcohol exposure compared to the later fetal stages [@B16]. Previous studies have suggested genetic susceptibilities to alcohol-mediated abnormalities. Microarray analysis and next-generation sequencing techniques have been applied to identify important developmental genes that are altered by maternal intake of alcohol during gestation [@B12]-[@B15], [@B17]-[@B20]. However, the specific genetic and epigenetic mechanisms behind alcohol-mediated abnormalities remain unknown. A combination of genetic and epigenetic approaches are needed to reveal the molecular mechanisms governing these disorders. In this review, we attempted to collect all the available information concerning exposure to ethanol *in utero* and the consequences of epigenetic alterations mediated by ethanol. We hope that this review will help researchers to better understand alcohol-directed epigenetic modifications, especially histone modifications, in teratogenicity.

Correlation between alcohol metabolism and histone modifications
================================================================

Metabolites and metabolic enzymes are involved in epigenetic mechanisms. Thus, the transcriptional regulation of rate-limiting metabolic enzymes is important for controlling metabolic changes in cells. The levels of metabolites (e.g., NAD^+^, ATP, acetyl-CoA, and S-adenosyl methionine (SAM)) and metabolic hormones (e.g., insulin, leptin) contribute to the regulation of gene expression. The activities of major enzymes involved in epigenetic modification are in part regulated by the concentrations of available substrates and cofactors [@B21]. Thus, cellular metabolites are involved in the transcriptional regulation of genes as well as in epigenetic mechanisms.

Alcohol is absorbed into the bloodstream by diffusion via small blood vessels in the walls of the stomach and the small intestine. Approximately 20% of ingested alcohol is absorbed through the stomach, while the remaining 80% is absorbed through the small intestine [@B22]. The small intestine has a large surface area that quickly allows for passage into the blood supply. The absorption of alcohol occurs more rapidly for beverages that have a higher alcohol content. A small proportion of ingested alcohol does not enter the systemic circulation and is oxidized in the stomach by alcohol dehydrogenase (ADH) enzymes, including class I and class III ADH molecules [@B23]. Following absorption, alcohol is transported to the liver, where it is enzymatically metabolized. The ability of the liver to metabolize alcohol is limited by time, and any excess is left to circulate throughout the body [@B23]. Thus, the intensity of alcohol\'s effects on the body is directly related to the amount consumed. Alcohol is also metabolized in tissues that do not contain ADH enzymes, such as in the brain, by the enzymes cytochrome P450 and catalase [@B24]. In general, alcohol metabolism is achieved through both oxidative and non-oxidative pathways. Alcohol oxidation occurs in the liver, where three major enzymes are responsible for completing the process. These enzymes are alcohol dehydrogenase, cytochrome P450 2E1 (CYP2E1), and catalase. ADHs, CYP2E1, and catalase are found in the cytosol, microsomes, and peroxisomes, respectively [@B25]. In the cytosol, ethanol is converted to acetaldehyde by the enzymatic action of ADH in the first step of the oxidative pathway. Nicotinamide adenine dinucleotide (NAD) accepts hydrogen atoms and electrons from alcohol to produce acetaldehyde. When alcohol intake is high, CYP2E1 is recruited to metabolize alcohol to acetaldehyde in the endoplasmic reticulum. Another minor pathway of alcohol oxidation is mediated by catalase in peroxisomes [@B26]. This pathway is capable of oxidizing ethanol in the presence of an H~2~O~2~-generating system. In the final step of this oxidative pathway, acetaldehyde is converted to acetate by mitochondrial acetaldehyde dehydrogenase. Much of the acetate produced through the oxidation of acetaldehyde leaves the liver and circulates to peripheral tissues [@B23], [@B25]-[@B27] (Figure [1](#F1){ref-type="fig"}). The non-oxidative pathway of ethanol metabolism involves the esterification of ethanol. The major enzyme involved in this pathway is fatty acid ethyl esters (FAEE) synthase, which forms esters from ethanol. Another product of the non-oxidative pathway is phosphatidylethanol, which is catalyzed by phosphatidylcholine-specific phospholipase D [@B23], [@B25], [@B27] (Figure [1](#F1){ref-type="fig"}).

Increased levels of acetate quickly escape the liver and reach the blood stream and other parts of the body. In mitochondria, acetate is transformed to acetyl-CoA by the enzyme acyl-CoA synthetase short-chain family member 2 (ACSS2) [@B28]. There are two primary acetate-activating enzymes: acyl-CoA synthetase short-chain family members 1 and 2 (ACSS1 and ACSS2), which are regulated by sirtuins. NAD^+^-dependent HDACs are known as sirtuins (SIRTs 1-7) and are located in the nucleus, cytoplasm, and mitochondria [@B29]. SIRT3 is a deacetylase that activates long-chain acyl-CoA dehydrogenase within the mitochondrial matrix [@B30]. Acetylation inactivates ACSS1 and ACSS2, whereas deacetylation activates them. SIRT1 and SIRT3 deacetylate ACSS2 and ACSS1, respectively. Sirtuin-mediated deacetylation, in conjunction with ACSS enzyme-mediated acetyl-CoA synthesis, elevates the conversion rate of acetate to acetyl-CoA in all cellular compartments. Thus, any differences in cellular acetate levels may hamper total protein acetylation. The resulting acetyl CoA then enters the Krebs cycle and combines with oxaloacetate to form citrate. Citrate is either oxidized within the Krebs cycle or exported to the cytoplasm where it subjected to cleavage into acetyl-CoA by the enzyme ATP-citrate lyase (ACL) in an ATP-dependent manner [@B28]. Furthermore, acetyl-CoA can also acetylate histone proteins, either by influencing acetyltransferase catalytic activity or non-enzymatically (Figure [2](#F2){ref-type="fig"}). In eukaryotic cells, acetyl-CoA is regarded as the sole donor of acetyl groups to acetylating proteins [@B31].

The NADH:NAD^+^ ratio affects transcriptional mechanisms through NAD^+^-dependent enzymatic activity. An NAD^+^-dependent enzyme, Sir2, exhibits histone deacetylase (HDAC) activity, which can induce gene silencing [@B32]. Gene silencing, circadian rhythm regulation, and other cellular functions require NAD^+^-dependent HDAC activity [@B33], [@B34]. As substrates of SIRT1, histone and p53 proteins are subject to conformational changes dictated by the ratio of NADH:NAD^+^. We have noticed that chronic alcohol exposure resulted in reduced NAD+ levels, required for sirtuin\'s deacetylase activity, and caused damage to the liver and other organs [@B35]. Metabolic reactions produce redox potential that plays an important role in circadian rhythm functioning. Previous studies have suggested that ethanol exposure (both acute and chronic) alters several aspects of the circadian rhythm [@B36]-[@B39].

SAM is the primary methyl group donor and is generated in the methionine cycle from methionine and ATP [@B11], [@B40]. Many studies have shown that folate deficiency reduces SAM levels and the SAM to S-adenosyl homocysteine (SAH) ratio, and increases SAH concentrations by inactivating methionine synthase (MS) and methionine adenyltransferase (MAT) [@B41], [@B42]. Elevated levels of SAH inhibit HMTs-mediated histone methylation [@B43], [@B44] (Figure [2](#F2){ref-type="fig"}). We already know that chronic alcohol consumption reduces the serum folate level [@B45], [@B46]. The Krebs cycle intermediates, succinate and fumarate, have been identified as inhibitors of Jumonji-C (JMJC) domain-containing histone demethylases (JHDMs) and promote methylation [@B47], [@B48].

ATP is a substrate for kinases in the phosphorylation process. Typically, kinases have a high affinity for ATP but its availability does not influence kinase activity. However, But AMP-activated protein kinase (AMPK) is involved in sensing the cellular energy level and becomes activated to phosphorylate histone proteins [@B49] (Figure [2](#F2){ref-type="fig"}). Like AMPK, many chromatin-modifying enzymes are also regulated by the availability of metabolites and can influence the capacity to write or erase post-translational modifications in the chromatin. Another aspect of alcohol metabolism is that it increases cellular ROS levels. Elevated ROS levels induce intracellular oxidative stress and can alter transcriptomic and epigenetic mechanisms [@B50], [@B51]. It was observed that superoxide plays an important role in regulating epigenetic events, including histone methylation and acetylation [@B52], in various normal and pathological processes.

Evidence of alcohol-mediated modification of histone marks
==========================================================

Epigenetic changes may be responsible for some of the detrimental effects of *in utero* alcohol exposure and may contribute to the abnormalities seen in FASD. The role of epigenetic mechanisms during prenatal alcohol exposure occurs in the early stages of development. Published studies (*in vitro* and *in vivo*) have shown that ethanol is responsible for protein modifications, particularly of the histones. Protein modifications may occur directly or indirectly, by disrupting epigenetic processes. Previous reports have suggested that ethanol can alter histone modifications, including acetylation, methylation, and phosphorylation, as discussed below.

Acetylation
-----------

*In utero* alcohol exposure is involved to cause both hyper- and hypoacetylation of histone protein in the fetus. The very first report of histone acetylation demonstrated that acute alcohol exposure caused acetylation of histone H3K9/18 and preceded apoptosis in fetal lung tissue [@B53]. Hyperacetylation of H3K9 was also reported in cardiac progenitor cells *in vitro* [@B54]. A similar result was also documented in the fetal heart, where ethanol induced H3K9 hyperacetylation and an alternation of gene expression related to heart development [@B55]-[@B57]. Extensive research recently showed that alcohol significantly enhanced the levels of phosphorylated ERK1/2 and induced hyperacetylation of histone3 in H9c2 cells [@B58]. Another report showed that ethanol exposure increased global HAT activity in the fetal hearts of mice without affecting HDAC activity. Thus, ethanol is involved in hyperacetylation in different parts of the developing fetus and can cause an elevation of the expression of developmental genes, including *NKX2.5*, *β-MHC* and *Cx43* in the fetal heart [@B59]. Ethanol enhanced the specific acetylation of H3K14 at G9a exon 1 in the brain during synaptogenesis in a rodent model [@B60]. Hyperacetylation of H3K14 and induction of *DHAND* and *EHAND* genes was also reported in the developing fetal heart [@B61]. Ethanol-induced neonatal neurodegeneration enhanced the CB1R exon 1 acetylation signature at H4K8 [@B62]. It was also reported that ethanol elevated mRNA levels of histone modifying genes (*HDAC2*, *HDAC4* and *G9a*) at the mRNA level in the fetal rat brain [@B63].

*In utero* alcohol exposure is also reported to cause hypoacetylation of histone protein in the developing fetus and reduced expression of related genes. Decreased levels of H3 and H4 acetylation were reported in the developing rat cerebellum due to the down-regulation of histone acetyl-transferase and CREB binding protein (CBP) [@B64]. They also reported hypoacetylation of H3K23 in the fetal brain. Another interesting finding showed that ethanol caused a reduction in the H3K9 acetylation level in the fetal brain [@B65], [@B66]. This contrasting phenomenon suggests that the ethanol-mediated alterations are context-dependent. A summary of alcohol-mediated effects on histone acetylation is presented in Table [1](#T1){ref-type="table"}.

Methylation
-----------

The ability of ethanol to influence histone methylation marks has also been reported. We have observed ethanol-mediated methylation as well as demethylation of histone protein. To the best of our knowledge, the first report concerning ethanol-mediated histone methylation was published by Govorko and colleagues [@B65]. They identified a reduction in H3K4me2, H3K4me3 and an increase in H3K9me2 marks in the arcuate nucleus of the hypothalamus in rat neonates. They also found a correlation between alcohol exposure and the reduced expression of *Set7/9* and an induction of *G9a* and *Setdb1* at the mRNA level. Set7/9, G9a and Setdb1 are responsible for the mono-methylation of H3k4, demethylation of H3k9me2 and mono-, di-, and trimethylation of H3K9, respectively. Recently, several reports on histone methylation have strengthened the notion that prenatal alcohol exposure can alter histone epigenetic marks in the developing fetus. Ethanol exposure caused a significant reduction in H3K4 trimethylation and H3K27 trimethylation in fetal cerebral cortical neuroepithelial stem cells [@B67]. Ethanol increased the specific methylation mark, H3K9me2, during the synaptogenesis period in a rodent model [@B60]. *In utero* ethanol exposure was reported to induce the H3K4me3 signature in the adult hippocampus [@B68]. The expression of the epigenetic modulator, KDM6B, was suppressed by ethanol during odontogenic/osteogenic differentiation in the DPSC model [@B69]. Osteopenia/osteoporosis is the hallmark feature of fetal alcohol spectrum disorders. A recent finding has shown that acute alcohol exposure on day 7 of gestation caused a significant alteration in the chromatin structure on day 17 [@B70]. A low dose of ethanol elevated the H3K4me3 and H3K27me3 marks, whereas a higher dose depleted these histone marks. The depletion of H3K9me2 was correlated with higher doses of ethanol. It was also described that the majority of epigenetic changes were associated with a repressed chromatin structure that correlated with the decreased expression of *Dnmt1*, *Eed*, *G9a*, *EzH2*, *Kdm1a*, *Kdm4c*, *Setdb1*, *Sod3*, *Tet1* and *Uhrf1* [@B70]. We noticed that most researches focused on reporting epigenetic alterations in the fetal brain, compared to other parts of the fetus. Thus, much remains to be elucidated concerning alcohol-mediated histone modifications in fetal development. A summary of ethanol-mediated alterations of histone methylation is presented in Table [1](#T1){ref-type="table"}.

Phosphorylation
---------------

Recent studies have shown that the MAPK signaling pathway plays a pivotal role in the actions of ethanol in the cell. The exposure to the neural crest cells to ethanol resulted in the induction of p38 MAPK phosphorylation [@B71]. The phosphorylation of histone H3 at serine 10 and serine 28 has been associated with gene expression and regulation [@B72]. However, there is little direct evidence of prenatal alcohol exposure affecting the phosphorylation of histone protein in literature reports. The only available evidence is that prenatal alcohol exposure reduces the phosphorylation of histone H3 at serine 10 (pH3S10) [@B66]. Similar reports describe the alteration of histone H3 phosphorylation at the serine 10 and serine 28 residues in the rat liver [@B73], [@B74]. Acute EtOH exposure altered the intensity of histone H3 phosphorylation at the serine 10 in the rat hippocampus [@B75]. Further investigation is needed to uncover direct evidence for prenatal alcohol exposure and the subsequent phosphorylation of histone protein. It was recently reported that the phosphorylation of histone H3 at serine 10 and serine 28 is associated with histone acetylation, in particular, H3K9ac and H3K14ac, in EGF-stimulating cells [@B72]. Thus, it will be interesting to elucidate whether alcohol-mediated phosphorylation of histone H3 phosphorylation at the serine 10 and serine 28 is also associated with other histone modifications. A summary of alcohol-mediated phosphorylation of histones *in utero* is presented in Table [1](#T1){ref-type="table"}.

Future perspectives and concluding remarks
==========================================

Prenatal alcohol exposure causes damage to the developing fetus through direct and indirect mechanisms. Excessive alcohol exposure can results in postnatal FASD or FAS. Various signaling pathways, cell types, and underlying molecular mechanisms are known to be induced or inhibited by ethanol, but the epigenomic and epigenetic mechanisms affected by ethanol exposure are less well known. Recent research has reported on the effects of alcohol on histone modifications. However, we still do not know the relationship between specific histone modifications and FASD phenotypes (Figure [3](#F3){ref-type="fig"}). Another important avenue for future research is to identify drugs that can inhibit ethanol-mediated teratogenicity. Ethanol inhibits one-carbon metabolism and suppresses methyltransferase enzymes. Thus, supplemental folate would be useful in minimizing ethanol toxicity during gestation. Curcumin is used to inhibit histone acetylation and could thus be used to combat the effect of ethanol in the appropriate context. In this review, we have gathered information about the known relationships between alcohol exposure and histone modifications. Future studies will serve to further explain the mechanistic details of numerous deleterious effects associated with ethanol exposure *in utero*.

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP 2011-0030049 to Y.G.C.).

![**Alcohol metabolism in the body.** Following alcohol consumption, most is absorbed by the small intestine and the stomach. Through circulation, alcohol quickly reaches the liver, where it is broken down. Two major pathways are involved in ethanol metabolism: 1) the oxidative pathway, and 2) the non-oxidative pathway. 1) In the oxidative pathway, alcohol is metabolized to acetaldehyde by cytosolic alcohol dehydrogenase (ADH). If a large amount of ethanol is present, cytochrome P450 IIE1 (CYP2E1) in the endoplasmic reticulum may also be involved in alcohol metabolism. A minor oxidative reaction also occurs in the peroxisomes, where the catalase enzyme is responsible for alcohol metabolism. Consequently, the intermediate metabolite acetaldehyde is metabolized by aldehyde dehydrogenase 2 (ALDH2) to form acetate in the mitochondria. 2) Two enzymes are involved in the non-oxidative pathway. In the presence of fatty acids, ethanol is metabolized to fatty acid ethyl ester (FAEE) by FAEE synthase. A phosphatidylcholine-specific enzyme named phospholipase D is involved in producing phosphatidylethanol from ethanol. The products of both the oxidative and non-oxidative pathways are quickly released into circulation, through which ethanol metabolites affect the peripheral organs. EtOH, ethanol; CH~3~CHO, acetaldehyde; H~2~O~2~, hydrogen peroxide; NAD/NADH, nicotinamide adenine dinucleotide; ROS, reactive oxygen species.](ijbsv13p1100g001){#F1}

![**Correlation between alcohol metabolites and histone modification.** In the liver, ethanol is converted to acetate through the action of different metabolic enzymes. Increased levels of acetate quickly escape the liver and reach the blood stream and other parts of the body. In mitochondria, acetate is transformed to acetyl-CoA by the enzyme acyl-CoA synthetase short-chain family member 2 (ACSS2). The resulting acetyl CoA then enters the Krebs cycle and combines with oxaloacetate to form citrate. Citrate is either oxidized within the Krebs cycle or exported to the cytoplasm, where it subjected to cleavage into acetyl-CoA by the enzyme ATP-citrate lyase (ACL). Acetyl-CoA is the sole donor of acetyl groups to acetylate histone proteins, either by influencing acetyltransferase catalytic activity or non-enzymatically. An elevated level of acetate from alcohol metabolism also causes an increase in the NADH:NAD^+^ ratio. An increased NADH:NAD^+^ ratio causes functional impairment of NAD^+^-dependent enzymes and results in histone deacetylation. Alcohol-mediated folate deficiency reduces S-adenosylmethionine (SAM) level and the SAM to S-adenosyl homocysteine (SAH) ratio as well as increases the SAH concentration, which in turns inhibits histone methyl transferase (HMT). Additionally, the intermediate products of the Krebs cycle, fumarate and succinate, act as inhibitors of Jumonji-C domain-containing histone demethylases (JHDMs). AMP-activated protein kinase (AMPK) is involved in sensing ATP fluctuation in cells and becomes activated to phosphorylate histone proteins. Formation of energetic stress causes the activation of AMPK and leads to histone phosphorylation. H~2~O~2~: Hydrogen peroxide; H~2~O: Water; ADH: Alcohol dehydrogenase; NAD/NADH: Nicotinamide adenine dinucleotide; CYP2E1: Cytochrome P450 IIE1; ALDH: Aldehyde dehydrogenase; CoA-SH: CoA synthase; KAT: Lysine acetyltransferase; SIRT: Sirtuin; FA: Folic acid; THF: Tetrahydrofolate; MTHF: methylene tetrahydrofolate; MS: Methionine synthase; MAT: Methionine adenyltransferase; GDP: Guanosine diphosphate; GTP: Guanosine triphosphate; ATP: Adenosine triphosphate; ADP: Adenosine diphosphate; AMP: Adenosine monophosphate.](ijbsv13p1100g002){#F2}

![**Summary of alcohol-mediated histone modifications *in utero*.** Gestational alcohol exposure causes epigenetic alteration in the developing fetus. Many histone marks are altered by alcohol during fetal development. Research suggests that alcohol can alter the expression level of several important epigenetic modulators that contribute to the alteration of histone marks. Current knowledge about alcohol toxicity indicates that it is able to affect acetylation/deacetylation, methylation/demethylation and phosphorylation of histone proteins. However, the correlation of these changes with the FASD phenotype remains unknown.](ijbsv13p1100g003){#F3}

###### 

Summary of alcohol-mediated histone modifications *in utero*.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Model organism                                               Pattern of alcohol exposure                                       Sampling                                                  Status of histone signature                                                                                                    Reference
  ------------------------------------------------------------ ----------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------ -----------
  Mouse                                                        25% ethanol (3.75 g/kg)                                           E13.5 lung                                                Induction of H3K9/18ac                                                                                                         [@B53]

  Cardiac progenitor cells                                     200 mM *in vitro*                                                 Cell culture exposed for 24 h                             Induction of H3K9ac                                                                                                            [@B54]

  Rat                                                          4 hr/day in the inhalation chamber (vapor of ethanol)             P8 brain (cerebellum)                                     Reduction of H3 and H4 acetylation.\                                                                                           [@B64]
                                                                                                                                                                                           The level of H3K23ac is also reduced.                                                                                          

  Cardiac progenitor cells                                     200 mM *in vitro*                                                 Cell culture exposed for 24 h                             Elevation of H3K9ac and the expression of *GATA4* and *Mef2c* genes.                                                           [@B56]

  Rat                                                          ethanol in liquid diet                                            P60-P80 of each generation (F1, F2 and F3); brain         Reduction of H3K4me2, H3K4me3 and H3K9ace marks; induction of H3K9me2 mark.\                                                   [@B65]
                                                                                                                                                                                           Reduction of mRNA levels of *Set7/9*; induction of *G9a* and *HDAC2* mRNAs.                                                    

  Rat                                                          6.7% v/v (in liquid diet) equivalent to ∼120-150 mg/dl in blood   P60-65 brain                                              Induction of H3K9me2 mark; deduction of H3K4me2, H3K4me3, H3K9ac, pH3S10 marks.\                                               [@B66]
                                                                                                                                                                                           Induction of mRNAs of*G9a* and *Setdb1*; reduction of *Set7/9* mRNA level.                                                     

  Mouse                                                        1.0 or 2.5 g/kg (subcutaneous injection)                          P7 brain                                                  Elevation of *G9a* mRNA and protein levels and G9a activity.\                                                                  [@B76]
                                                                                                                                                                                           Induction of H3K9me2 and H3K27me2.                                                                                             

  Mouse (fetal cerebral cortical neuroepithelial stem cells)   320 mg/dL (70mM)                                                  Neurosphere Culture exposed for 5 days                    Reduction of H3K4me3 mark at *Nestin, Sox2, Dlx2, Pax6* and *Vdr* gene promoters.\                                             [@B67]
                                                                                                                                                                                           Reduction of H3K27me3 mark at *Ascl1, Sox17, Twist1, Wnt5b, HoxA1, HoxA7, Msx2, Nanog, Nkx2.1* and *Nkx2.2* gene promoters.\   
                                                                                                                                                                                           Reduction of both H3K4me3 and H3K27me3 marks at *Igf1, Smarca2, Dlx5* and *Msx1* gene promoters.\                              
                                                                                                                                                                                           Global decline in the levels of H3K27me3 of the four transposable element families (LINE1, IAP, MusD and EtN).                 

  Mouse                                                        10 μl/g/d (56% alcohol) by gavage                                 E11.5, E14.5, E17.5, and E18.5 fetal heart                Induction of HAT activity and H3K9ac signature.                                                                                [@B55]

  Mouse                                                        5 ml/kg (56% v/v) intragastrically                                E14.5 and E16.5 fetal heart; P0.5 and P7 neonatal heart   Induction of HAT activity and binding of P300, CBP, PCAF and SRC1 to the *Gata4* promoter at E14.5.\                           [@B57]
                                                                                                                                                                                           Induces hyperacetylation of H3K9.                                                                                              

  Mouse                                                        1.0 g/kg (subcutaneous injection)                                 P7 brain                                                  Induction of H3K14ac at G9a exon1.\                                                                                            [@B60]
                                                                                                                                                                                           Elevation of H3K9me2 and H3K27me2 levels in the hippocampus and neocortex.                                                     

  Mouse                                                        2.5 g/kg (subcutaneous injection)                                 P7 brain                                                  Elevation of H4K8ac and reduction of H3K9me2 at exon1 of the *CB1R* gene.                                                      [@B62]

  Mouse                                                        6 g/kg/d (56%) intragastrically                                   E14.5 fetal heart                                         Elevation of H3K14ac mark and the expression of *DHAND* and *EHAND* genes.                                                     [@B61]

  Mouse                                                        2.5 g/kg (subcutaneous injection)                                 P7 brain                                                  Reduction of H3K9me2 mark.                                                                                                     [@B77]

  Rat (Fetal heart-derived cell line)                          200 mM *in vitro*                                                 H9c2 cell culture                                         Induction of H3 acetylation level.                                                                                             [@B58]

  Mouse                                                        5 ml/kg (56% v/v) intragastrically                                E14.5 and E16.5 fetal heart; P0.5 and P7 neonatal heart   Hyperacetylation of histone H3K9 on the *NKX2.5* promoter.                                                                     [@B59]

  Rat                                                          6.7% v/v (in liquid diet) equivalent to 120-150 mg/dl in blood    P60-P90 pituitary gland                                   Elevation of pituitary mRNA levels of histone modifying genes (*HDAC2, HDAC4, G9a*).                                           [@B63]

  Mouse                                                        10% v/v in drinking water                                         P87 hippocampus                                           Enrichment of histone H3K4me3 mark at the *Slc17a6* promoter.\                                                                 [@B68]
                                                                                                                                                                                           Induction of chromatin modifying enzymes (Dnmt1, Uhrf1, Ehmt1, Ash2l, Wdr5, and Kdm1b).                                        

  Mouse                                                        2.9 g/kg (intraperitoneal injection)                              E17 forebrain                                             Elevation of H3K9me2, H3K9ace marks and reduction of H3K27me3 mark.\                                                           [@B70]
                                                                                                                                                                                           Reduction of *G9a, Setdb1, Kdm1a, Kdm4c, Uhrf1, Ezh2* and *Dnmt1* mRNA levels.                                                 

  Human dental pulp stem cells (DPSCs)                         20 or 50 mM (both acute and chronic exposure)                     DPSC cell culture                                         Suppression of *KDM6B* mRNA level.                                                                                             [@B69]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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